Letter to the Editor
Dear Editor, Hypokalemic periodic paralysis (HPP) is a rare neuromuscular disorder caused by dysfunction of the ion channels in red muscle cells and which is characterized by painless episodes of muscle weakness generally after strenuous exertion or a high-carbohydrate meal. 1 Most HPP cases are hereditary since the disease is autosomal dominant. However, some patients who develop HPP secondary to thyrotoxicosis are also described. Thyrotoxic hypokalemic periodic paralysis (THPP), unlike other thyroid diseases, is predominantly seen in men. 2 Here we report the case of a patient with no known chronic illness who presented with paralysis and who was subsequently diagnosed as having thyrotoxicosis with hypokalemic periodic paralysis being caused by his thyroid disease.
A 41-year-old Caucasian man, without any chronic disease, presented to our emergency department with generalized muscle weakness that was especially pronounced in both his upper and lower extremities. He recalled many similar but milder episodes in the previous two months. The physical examination made by a neurologist identified no pathology but only quadriparesis (bilateral upper extremities 3/5, bilateral lower extremities 4/5). His initial potassium level was 1.5 mEq/L on admission and his electrocardiogram showed an obvious U wave (Figure 1 ). An initial diagnosis of hypokalemic periodic paralysis was made and he was immediately given intravenous potassium chloride in the emergency department. He was then interned and, after he had been provided a detailed anamnesis, it was learned that he had no family history like his own and that he had had a high-carbohydrate meal a few hours before the quadriparesis occurred. On admission, blood pressure was 140/80 mmHg and heart-rate 90 beats/minute. Physical examination revealed a slightly enlarged thyroid gland without nodules, while exophthalmos was also present. The clinical findings of other systems were normal. Thyroid stimulating hormone (TSH) level was <0.03 μU/mL (0.25-5.0), On the basis of these findings, the patient was diagnosed as having THPP associated with Graves' thyrotoxicosis, and treatment with methimazole was initiated. Serial measurements of his serum potassium level, which was too low on admission and then became normal after administration of intravenous potassium chloride, remained within normal limits without any oral potassium supplements in the hospital. Treatment with propranolol was also initiated at 4×40mg per day and the patient was discharged with the diagnosis of THPP secondary to Graves' disease.
THPP is a sporadic form of HPP and occurs in association with hyperthyroidism. In most cases of THPP, the main underlying cause is Graves' disease. More than 95% of THPP cases are seen in men, despite the greater tendency of women to have thyroid diseases. The pathogenesis of THPP, which is a rare complication of thyrotoxicosis causing hypokalemia only during episodes, is the activation of the Na + / K + -ATPase pump because of hyperinsulinemia and the increase of thyroid hormones, catecholamines and beta-adrenergic stimulation. Besides these latter factors, resting after exercise can also increase Na + / K + -ATPase activity in skeletal muscle, promoting an influx of potassium. 3, 4 Therefore, B receptor blockage, anti-thyroid drugs and instructing patients to avoid such precipitating factors as high-carbohydrate meals are recommended for treatment and prophylaxis of THPP instead of administering potassium only. 5 Unless there are cardiopulmonary complications, KCl infusion should be given, however, at a slow rate because it may result in rebound hyperkalemia as potassium shifts back into the intravascular compartment. 6 The aim of this letter is to share this case of THPP in a patient, who, like most patients described in the literature, was not aware of his thyroid disease. By presenting this case, we wish to emphasize the importance of carrying out a good anamnesis and physical examination, which will lead to a right diagnosis and successful treatment.
